# Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder

> **NCT00872131** · — · COMPLETED · sponsor: **University of Michigan** · enrollment: 200 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT00872131
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872131, "Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00872131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*